Exploring translational challenges and strategies for advancing gene therapies in neurodegenerative diseases

Jokūbas Leikauskas, Editor, BioInsights, speaks to Joseph Scarrott, Process Development/R&D Lead, Gene Therapy Innovation and Manufacturing Centre (GTIMC) at the University of Sheffield, about translational gene therapies for neurodegenerative diseases, focusing on efforts to improve safety, efficacy, and cost–effectiveness, and accelerate research to clinical-grade manufacturing.

Please enter your email to access content Read now